Introduction {#sec1-1}
============

Infertility is defined as failure to achieve a successful pregnancy after 12 months or more of regular unprotected intercourse ([@ref1]). Its prevalence is not negligible, since about 48.5 million couples worldwide do not reach pregnancy after 5 years ([@ref2]). Overall, about 50% of cases are due to a male factor infertility ([@ref3]). Genetic causes have been estimated to exist in about 15% of infertile patients, especially in those with azoospermia or severe oligozoospermia ([@ref3]).

Genetic causes of male infertility can be classified as pre-testicular (affecting hypothalamic-pituitary function), testicular (causing dysfunction at testicular level) and post-testicular (leading to obstruction or interfering with ejaculation of sperm). Other causes include androgen resistance and disorders of sexual development. Genetic causes of male infertility are outlined in [Table 1](#T1){ref-type="table"}.

###### 

Main causes of genetic forms of male infertility.

  ------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Pre-testicular causes    Normosmic hypogonadotropic hypogonadismAnosmic hypogonadotropic hypogonadism (Kallmann syndrome)Prader-Willy syndromeLaurence-Moon-Biedl syndromeOthers
  Testicular forms         Klinefelter syndromeNumerical chromosomal abnormalitiesY chromosome microdeletionsChromosomal translocationsDown syndromeMyotonic dystrophy (Steinert syndrome)
  Post-testicular causes   Kartagener syndromeCongenital bilateral deferent duct agenesisYoung syndrome
  Others                   Androgen resistanceDisorders of sexual development
  ------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------

Despite a proper diagnostic work-up, the etiology of male infertility remains elusive in up to 75% of cases ([@ref4]). In recent years, much effort has been made to investigate new candidate genes responsible for male infertility caused by single-gene mutations ([@ref5],[@ref6]). Several genes involved in meiotic and mitotic divisions and in spermiohistogenesis have been examined as potential targets. They may play a role in the pathogenesis of defects of sperm number (oligozoospermia or azoospermia), motility (asthenozoospermia) or morphology (teratozoospermia) ([@ref7]).

In this review we describe genes belonging to the panels developed by us for the diagnosis of monogenic spermatogenic failure and androgen insensitivity syndrome.

Genes involved in sperm number defects {#sec1-2}
======================================

Sperm number defects include azoospermia and oligozoospermia. Azoospermia is the absence of spermatozoa in semen. It affects 1% of the male population and accounts for 20% of all cases of male infertility ([@ref8]). In about the 40% of patients, spermatogenesis occurs in a regular way but sperm emission is impaired by seminal duct obstruction (obstructive azoospermia) ([@ref9]); in the other cases, azoospermia is due to spermatogenic failure (non-obstructive azoospermia) ([@ref10]). Genetic causes of azoospermia include chromosome anomalies (numerical or structural aberrations of autosomal or sexual chromosomes) that affect 5% of all infertile males and 16% of males with azoospermia or oligozoospermia ([@ref11]). In 5-15% of cases, azoospermia or oligozoospermia is associated with Y chromosome microdeletions; 6-8% of cases with obstructive azoospermia are associated with mutations in the cystic fibrosis transmembrane receptor gene (*CFTR*) that causes congenital bilateral absence of the *vas deferens* ([@ref11]). Point mutations that cause azoospermia were recently found in the following genes: *NR5A1, SYCP3, ZMYND15, TAF4B, TEX11 NANOS1, PLK4, MEIOB, SYCE1, USP9Y, SOHLH1, TEX15, HSF2* and *KLHL10* ([@ref12]-[@ref19]) ([Table 2](#T2){ref-type="table"}).

###### 

Genes associated with spermatogenic failure

  Gene         Inheritance   OMIM gene   OMIM phenotype   OMIM or HGMD phenotype ID   Spermatogenic defect
  ------------ ------------- ----------- ---------------- --------------------------- -----------------------
  *NR5A1*      AR            184757      SPGF8            613957                      AZS/OZS
  *SYCP3*      AD            604759      SPGF4            270960                      AZS/OZS
  *ZMYND15*    AR            614312      SPGF14           615842                      AZS/OZS
  *TAF4B*      AR            601689      SPGF13           615841                      AZS/OZS
  *TEX11*      XLR           300311      SPGFX2           309120                      AZS
  *NANOS1*     AD            608226      SPGF12           615413                      AZS/OZS/OZS+ASTHZ+TZS
  *PLK4*       AD            605031      /                1556988045                  AZS
  *MEIOB*      AR            617670      SPGF22           617706                      AZS
  *SYCE1*      AR            611486      SPGF15           616950                      AZS
  *USP9Y*      YL            400005      SPGFY2           400042                      AZS
  *SOHLH1*     AD            610224      SPGF32           618115                      AZS
  *TEX15*      AR            605795      SPGF25           617960                      AZS/OZS
  *HSF2*       AD            140581      /                702994563                   AZS
  *KLHL10*     AD            608778      SPGF11           615081                      OZS; TZS; AZS
  *AURKC*      AR            603495      SPGF5            243060                      TZS (macrozoospermia)
  *DPY19L2*    AR            613893      SPGF9            613958                      TZS (globozoospermia)
  *SPATA16*    AR            609856      SPGF6            102530                      TZS (globozoospermia)
  *PICK1*      AR            605926      /                247048065                   TZS (globozoospermia)
  *BRDT*       AR            602144      SPGF21           617644                      ASS
  *SUN5*       AR            613942      SPGF16           617187                      ASS
  *SLC26A8*    AD            608480      SPGF3            606766                      AZS
  *CATSPER1*   AR            606389      SPGF7            612997                      AZS
  *SEPT12*     AD            611562      SPGF10           614822                      AZS; OZS+ASTHZ+TZS
  *CFAP43*     AR            617558      SPGF19           617592                      MMAF
  *CFAP44*     AR            617559      SPGF20           617593                      MMAF
  *DNAH1*      AR            603332      SPGF18           617576                      MMAF
  *PLCZ1*      AR            608075      SPGF17           617214                      OAF

SPGF = spermatogenic failure; OZS = oligozoospermia; AZS = azoospermia; ASTHZ = asthenozoospermia; TZS = teratozoospermia; OZS+ASTHZ+TZS = oligoasthenoteratozoospermia; ASS = acephalic spermatozoa syndrome; MMAF = multiple morphological abnormalities of the flagellum; OAF = oocyte activation failure; AR = autosomal recessive; AD = autosomal dominant; XLR = X-linked recessive; YL = Y-linked; HGMD = Human Gene Mutation Database (https://portal.biobase-international.com/hgmd/pro/)

Frameshift mutations in *ZMYND15* cause the SPGF14 phenotype. The protein encoded by this gene is involved in temporally normal haploid gene expression during spermatogenesis ([@ref13]).

A homozygous mutation in *SYCE1* is associated with the SPGF15 phenotype. This gene encodes a member of the synaptonemal complex, a structure that physically links homologous chromosomes during meiosis I ([@ref14]).

Mutations in *TEX11* have been associated with meiotic arrest and azoospermia with a frequency of 1-15% in the azoospermic males. *TEX11*-encoded protein regulates the coupling of homologous chromosomes in double-strand DNA repair through formation of the synaptonemal complex and the chiasma during the crossover process ([@ref20]). A similar role is performed by SYCP3 that has also been found mutated in sterile men ([@ref16]).

*SOHLH1* is mutated in some cases of azoospermia and encodes a testicular transcription factor essential for spermatogenesis ([@ref21]).

A mutation in *NR5A1*, encoding steroidogenic factor 1, has been reported in a Pakistani patient with meiotic arrest and normal levels of follicle-stimulating and luteinizing hormones, and testosterone ([@ref22]).

Finally, a patient with spermatogenesis blocked at the spermatocyte stage had a dominant negative mutation in *HSF2*, encoding heat shock transcription factor 2 ([@ref23]).

Genes involved in defects of sperm morphology {#sec1-3}
=============================================

Teratozoospermia is a heterogeneous group of disorders. Sperm morphological evaluation considers the main functional regions (head, body and tail), which may have anomalies in shape and size. Phenotype may involve a single type of malformation in a single patient or different types of malformation in the same patient ([@ref24]). Recent studies in consanguineous families and small phenotypically homogeneous cohorts has made it possible to identify autosomal recessive cases of teratozoospermia.

Macrozoospermia is a rare condition observed in \<1% of infertile men. It is characterized by a high percentage of sperm with large irregularly-shaped heads, multiple flagella and abnormal acrosome. Macrozoospermia is generally associated with severe oligoasthenozoospermia and a high rate of sperm chromosomal anomalies. Homozygous mutations in *AURKC* are the major cause of macrozoospermia. *AURKC* is highly expressed in male germline cells and is involved in chromosomal segregation and cytokinesis ([@ref25]).

Globozoospermia is a rare condition characterized by round sperm lacking acrosomes. Genes reported mutated in patients with this condition are *SPATA16* and *DPY19L2*. *SPATA16* encodes a protein specific to Golgi apparatus, highly expressed in the testes. A genetic study in a single consanguineous family with male infertility due to globozoospermia revealed a homozygous variant in the three affected siblings ([@ref26]). Subsequent studies identified mutations in *DPY19L2* in 66.7% of 54 probands with globozoospermia ([@ref25]). The protein encoded by *DPY19L2* is necessary for elongation of the sperm head and acrosome formation during spermatogenesis ([@ref27]).

To date, more than 20 cases of patients with acephalic sperm have been reported. Biallelic mutations in *SUN5* can be found in 47% of cases ([@ref28]), and a homozygous mutation in *BRDT* has been reported in a consanguineous family ([@ref27]).

Genes currently associated with morphological sperm defects are: *AURKC, ZPBP, DPY19L2, SPATA16, PICK1, BRDT* and *SUN5* ([Table 2](#T2){ref-type="table"}).

Genes involved in sperm motility defects {#sec1-4}
========================================

Asthenozoospermia is a condition leading to reduced sperm motility due to defects in the flagellum. The axoneme, outer dense fibers, mitochondria or fibrous sheath of the flagellum may be affected ([@ref30]). Ultrastructural defects in 9+2 axoneme structure may involve the outer or inner dynein arms, central microtubules and radial spokes.

Biallelic mutations in *DNAH1*, that encodes heavy chain 1 of axonemal dynein expressed in the testis, cause a heterogeneous group of anomalies defined as multiple morphological anomalies of the flagellum (MMAF) ([@ref31],[@ref32]). Mutations in *DNAH1* are the major cause of MMAF and account for 28-44% of cases ([@ref33]). In four out of 30 Chinese subjects with MMAF, Tang et al. identified mutations in either *CFAP43* or *CFAP44*. The proteins encoded, CFAP43 and CFAP44, are cilium- and flagellum-associated, almost exclusively expressed in the testis.

The genes associated with sperm motility defects are: *SLC26A8, CATSPER1, SEPT12, CFAP43, CFAP44, DNAH1* and *PLCZ1* ([Table 2](#T2){ref-type="table"}).

We uses a multi-gene NGS panel to detect nucleotide variations in coding exons and flanking introns of the aforementioned genes ([Table 2](#T2){ref-type="table"}). Pathogenic variants may be missense, nonsense, splicing or small indels. Large deletions/duplications have been reported in *USP9Y*, *DPY19L2*, *SPATA16*, *SUN5* and *CFAP43*. We use MLPA to detect duplications and deletions in the latter genes.

Androgen insensitivity syndrome {#sec1-5}
===============================

Androgens and their receptor are essential for the development and maintenance of the male phenotype and spermatogenesis. The gene *AR* encoding the androgen receptor is X-linked and the encoded protein is a nuclear receptor that recognizes the canonical androgen response elements on the genome ([@ref34]).

Mutations in *AR* (OMIM gene ID: 313700) cause a spectrum of conditions defined as androgen insensitivity syndromes (OMIM phenotype ID: 300068), which are disorders of sexual development characterized by external female genitalia, ambiguous genitalia or virilization defects, 46, XY karyotype and little or no response to androgens. Androgen insensitivity syndromes (AIS) may be complete or partial. Patients with the complete form have a female phenotype with little or no pubic/axillary hair or secondary sexual features and a 46, XY karyotype ([@ref35]).

Mutations can be found throughout the gene, but are more frequent in five exons that encode ligand-binding domains. The androgen insensitivity syndrome phenotype is due to loss-of-function mutations in *AR*, making target cells insensitive to testosterone or dihydrotestosterone. In 95% of cases, a mutation in the *AR* gene can be detected. In 30% of cases the mutations are *de novo*. The disorder is inherited with a X-linked recessive inheritance ([@ref36]).

Clinical diagnosis is based on symptoms and biochemical features of 46, XY females. The typical hormonal profile of adults includes increased basal concentrations of luteinizing hormone and testosterone. Serum levels of anti-Mullerian hormone may be normal or elevated. Subjects with partial loss-of-function mutations in *AR* (partial AIS) can have infertility as first or only symptom. Partial androgen insensitivity syndrome may be suspected in infertile males with high plasma levels of testosterone and LH, although a precise threshold has not yet been established ([@ref36]).

Interestingly, mutations in *AR* can be identified in 2-3% of cases of azoospermia and oligozoospermia ([@ref38]). There may be a genotype-phenotype correlation in AIS patients, as reported in the Androgen Receptor Gene Mutations Database ([@ref39]), whereas a correlation in partial AIS patients is less clear and the same mutations can express as different phenotypes ([@ref37]). The *AR* gene may therefore be included among candidate genes in patients with apparently idiopathic azoospermia or oligozoospermia.

Conclusions {#sec1-6}
===========

We created a NGS panel to detect nucleotide variations in coding exons and flanking regions of all the genes associated with infertility. When a suspect of male infertility is present we perform the analysis of all the genes present in this short article.

In order to have a high diagnostic yield, we developed a NGS test that reaches an analytical sensitivity (proportion of true positives) and an analytical specificity (proportion of true negatives) of ≥99% (coverage depth ≥10x).
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